Leadership Overview
Zoetis has 4 executives leading key functions including financial oversight, technology transformation, executive operations, and information systems.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines, vaccines, and diagnostic products to improve the lives of livestock and companion animals across global markets.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines, vaccines, and diagnostic products to improve the lives of livestock and companion animals across global markets.
Leadership Roles at Zoetis
Lee Penn - Senior Director, Chief of Staff, Office of the Chief Executive Officer
Lee Penn, the Senior Director, Chief of Staff, Office of the Chief Executive Officer at Zoetis, coordinates strategic initiatives and facilitates communication between the executive leadership team and the Board. Managing the daily operations of the Office of the Chief Executive Officer, the Senior Director, Chief of Staff, Office of the Chief Executive Officer ensures that corporate objectives regarding animal health medicines and vaccines receive consistent focus. Lee Penn synthesizes complex data from various departments to provide actionable insights for high-level decision-making. By aligning cross-functional teams with the overarching mission of the company, the Senior Director, Chief of Staff, Office of the Chief Executive Officer drives organizational cohesion. This leadership role involves managing critical projects that impact the global commercialization of pharmaceutical products. Through meticulous planning and stakeholder engagement, the Senior Director, Chief of Staff, Office of the Chief Executive Officer supports the execution of long-term growth strategies and maintains operational excellence across all business units.
Renato Vilas Boas - Regional Chief Financial Officer, Latin America (Canada)
Renato Vilas Boas, the Regional Chief Financial Officer, Latin America (Canada) at Zoetis, directs all fiscal planning and financial reporting across the Latin American and Canadian markets. Managing complex budgetary requirements for animal health pharmaceutical distribution, the Regional Chief Financial Officer, Latin America (Canada) ensures strict adherence to international accounting standards while optimizing capital allocation for regional growth. Renato Vilas Boas monitors regional market volatility to protect profit margins on livestock and companion animal product lines. By collaborating with local veterinary distributors and retail partners, the Regional Chief Financial Officer, Latin America (Canada) drives sustainable revenue streams. This leadership role involves rigorous oversight of regional operational expenditures to support the broader corporate mission of delivering high-quality veterinary medicines. Through precise financial modeling and risk assessment, the Regional Chief Financial Officer, Latin America (Canada) secures the economic stability necessary for continued expansion within these critical geographic territories.
Mark Chomow - Chief Technology Officer & Head of Transformation & Portfolio Management
Mark Chomow, the Chief Technology Officer & Head of Transformation & Portfolio Management at Zoetis, architects the digital infrastructure supporting the discovery and manufacturing of animal health products. Overseeing the integration of advanced diagnostic technologies, the Chief Technology Officer & Head of Transformation & Portfolio Management drives the modernization of research pipelines to accelerate product development. Mark Chomow manages the strategic portfolio to ensure alignment between technological capabilities and market demands for livestock and companion animal pharmaceuticals. By streamlining internal processes, the Chief Technology Officer & Head of Transformation & Portfolio Management enhances operational efficiency across global manufacturing facilities. This leadership role requires constant evaluation of emerging biotech trends to maintain a competitive edge in the pharmaceutical industry. Through the implementation of scalable digital solutions, the Chief Technology Officer & Head of Transformation & Portfolio Management fosters innovation, ensuring that the company remains at the forefront of veterinary medicine and diagnostic excellence.
Michael Tao - Chief Information Officer, Greater (China, APAC)
Michael Tao, the Chief Information Officer, Greater (China, APAC) at Zoetis, directs the information technology strategy and data security protocols across the Asia-Pacific region. Overseeing the deployment of digital platforms for veterinary operations and supply chain management, the Chief Information Officer, Greater (China, APAC) ensures robust connectivity for regional sales representatives and technical specialists. Michael Tao manages the integration of advanced data analytics to track the performance of livestock and companion animal products in diverse markets. By strengthening cybersecurity measures, the Chief Information Officer, Greater (China, APAC) protects proprietary research and sensitive commercial data. This leadership role involves collaborating with global IT teams to standardize systems while addressing unique regional regulatory requirements. Through the optimization of information flow, the Chief Information Officer, Greater (China, APAC) enhances the efficiency of product distribution and customer engagement, directly contributing to the company's market penetration and operational success throughout the APAC region.
Explore Leadership Teams in Manufacturing
Boehringer Ingelheim is a privately held, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany, founded in 1885. The company researches, develops, and manufactures prescription medicines and healthcare products across three core business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its primary therapeutic focus areas include respiratory diseases, oncology, immunology, cardiometabolic conditions, and central nervous system disorders. Boehringer Ingelheim also develops and manufactures veterinary products for companion animals, livestock, and poultry. Operating in over 100 countries with more than 53,000 employees globally, the company maintains a broad network of research, manufacturing, and commercial sites across Europe, North America, and Asia. It is one of the largest privately owned pharmaceutical companies in the world.
Company Leadership SY
AG

CL
Proxima Research International LLC is a company that operates in the Pharmaceuticals industry. It employs 500to999 people and has 25Mto50M of revenue. The company is headquartered in Fort Lauderdale, Florida.
Company Leadership OK
AA
DD
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. They manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Company Leadership RR
MS
SC
JV
Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership TD
RP
PN
MS